AVALO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16 USD | -6.54% |
|
+12.68% | +75.82% |
| 17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
| 16/04 | Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35 | MT |
Chart calendar Avalo Therapeutics, Inc.
b57e943eed5456a15f4ce9f150003e49.Hx2Rc1WXQN8_liIzS4IvsfXd8OWGR3Qb6yYy9e2Ifvg.aVv1PzHZCZxG4m1rPt1b7r2pn5_fERsjmGNHs5zMLLBlftQDANRxq33iTQ~69a20f393bf09ff7d114fc44e78c2e5c
Upcoming events on Avalo Therapeutics, Inc.
Past events on Avalo Therapeutics, Inc.
| 30/03/2024 01:31 am | Q4 2023 Earnings Release |
| 28/03/2024 06:00 pm | Business Update Call |
| 20/12/2023 08:00 pm | Annual General Meeting |
| 09/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 03/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 11/07/2023 | SVB Securities Therapeutics Forum |
| 09/06/2023 08:30 pm | Jefferies Healthcare Conference |
| 19/05/2023 | Respiratory Innovation Summit |
| 17/05/2023 02:05 am | RBC Global Healthcare Conference |
| 05/05/2023 01:31 am | Q1 2023 Earnings Release |
| 29/03/2023 05:00 pm | Q4 2022 Earnings Release |
| 13/03/2023 10:50 pm | Oppenheimer Healthcare Conference |
| 07/11/2022 06:00 pm | Q3 2022 Earnings Release |
| 12/09/2022 04:30 pm | H.C. Wainwright Global Investment Conference |
| 04/08/2022 05:00 pm | Interim 2022 Earnings Release |
| 14/06/2022 07:00 pm | Annual General Meeting |
| 10/06/2022 01:30 am | Jefferies Healthcare Conference |
| 24/05/2022 04:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
| 05/05/2022 05:00 pm | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16,9 17,8 -4.74% | 6,70 6,20 8.05% | 5,40 6,08 -11.28% | 18,1 20,8 -13.2% | 1,92 1,70 13.18% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,1 -23,2 30.35% | -47,3 -69,3 31.71% | -82,1 -81,7 -0.55% | -37,4 -34,7 -7.91% | -27,4 -23,1 -18.4% | -33,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,7 -24,0 34.58% | -67,2 -63,6 -5.62% | -84,5 -82,8 -2.14% | -41,6 -39,7 -4.83% | -31,5 -26,8 -17.65% | -33,0 |
|
Net income Million USD | Released Forecast Spread | -16,1 -24,4 34.14% | -63,5 -61,0 -4.1% | -84,4 -82,9 -1.79% | -41,7 -36,8 -13.05% | -31,5 -26,8 -17.7% | -33,0 |
|
EPS USD | Released Forecast Spread | -806 -1 363 40.85% | -2 477 -2 434 -1.78% | -2 390 -2 396 0.24% | -1 063 -698 -52.23% | -114 -96,0 -18.75% | -0,91 |
| Announcement Date | 11/03/20 | 08/03/21 | 02/03/22 | 29/03/23 | 29/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,22 1,02 -78.49% | 1,17 0,52 127.15% | 1,03 0,74 38.98% | 14,9 1,26 1088.08% | 0,90 3,61 -75.18% | 0,48 1,00 -52.5% | 0,64 0,50 28.6% | 0,24 1,00 -76.4% | 0,57 0,30 90.33% | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,0 -17,4 -3.4% | -20,9 -15,2 -37.28% | -11,8 -16,5 28.34% | 4,10 -10,0 140.82% | -8,86 -7,07 -25.31% | -9,27 -9,20 -0.73% | -7,15 -10,1 29.33% | -3,75 -13,2 71.59% | -7,66 -3,40 -125.24% | -4,70 | -6,70 | -12,8 | -8,80 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,1 -17,2 -11.22% | -22,0 -16,8 -31.49% | -13,0 -16,8 22.63% | 3,20 -12,4 125.69% | -9,80 -7,90 -24.1% | -9,95 -9,20 -8.12% | -8,19 -10,0 18.46% | -5,22 -13,2 60.45% | -8,18 -3,40 -140.5% | -4,70 | -6,70 | -12,8 | -8,80 |
|
Net income Million USD | Released Forecast Spread | -19,2 -17,5 -9.49% | -22,1 -15,7 -40.33% | -13,0 -16,8 22.6% | 3,19 -12,4 125.65% | -9,81 -7,07 -38.85% | -9,96 -9,20 -8.21% | -8,19 -10,0 18.39% | -5,23 -13,2 60.39% | -8,17 -3,40 -140.24% | -4,70 | -6,70 | -12,8 | -8,80 |
|
EPS USD | Released Forecast Spread | -461 -455 -1.27% | -576 -360 -60% | -331 -425 22.03% | 81,6 -315 125.89% | -250 -176 -41.82% | -204 -233 12.37% | -142 -192 26.25% | -26,4 -264 90% | -113 -4,80 -2255.02% | -1,18 | -0,19 | -0,36 | -0,25 |
| Announcement Date | 02/03/22 | 05/05/22 | 04/08/22 | 07/11/22 | 29/03/23 | 04/05/23 | 03/08/23 | 09/11/23 | 29/03/24 | - | - | - | - |
| Today 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| Today 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| Today 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | REVOLUTION MEDICINES, INC.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | SYNDAX PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Avalo Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVTX Stock
- Calendar Avalo Therapeutics, Inc.
